Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
The study elucidates the prognostic factors that significantly impact the risk of developing MS symptoms in pwRIS at diagnosis, thereby, enhancing the potential for tailored clinical interventions.
Authors
- Jan Lycke (ORCID: https://orcid.org/0000-0002-7891-8466)
- Friederike Held (ORCID: https://orcid.org/0009-0008-1190-9435)
- Alfredo Rodríguez Antigüedad (ORCID: https://orcid.org/0000-0001-5975-725X)
- Mar Tintoré
- Sabine Schädelin (ORCID: https://orcid.org/0000-0002-1150-0962)
- Sara Llufriú (ORCID: https://orcid.org/0000-0003-4273-9121)
- Luciana Midaglia (ORCID: https://orcid.org/0000-0001-7981-2228)
- Igal Rosenstein (ORCID: https://orcid.org/0000-0002-5078-9690)
- Andreu Vilaseca (ORCID: https://orcid.org/0000-0001-8147-8505)
- Harald Hegen
- Jan D. Lünemann (ORCID: https://orcid.org/0000-0002-3007-708X)
- Hayrettin Tumani (ORCID: https://orcid.org/0000-0002-1647-6201)
- María Trojano (ORCID: https://orcid.org/0000-0002-6329-8946)
- Bernhard Hemmer (ORCID: https://orcid.org/0000-0001-5985-6784)
- Eva M. M. Strijbis (ORCID: https://orcid.org/0000-0001-6705-5864)
- Francisco Pérez‐Miralles (ORCID: https://orcid.org/0000-0003-3767-3738)
- Xavier Montalbán (ORCID: https://orcid.org/0000-0002-0098-9918)
- Stefan Bittner (ORCID: https://orcid.org/0000-0003-2179-3655)
- Antonio Sánchez (ORCID: https://orcid.org/0000-0001-7168-6175)
- Sara Eichau (ORCID: https://orcid.org/0000-0001-9159-3128)
- Ángel Pérez Sempere (ORCID: https://orcid.org/0000-0002-0195-2834)
- Jens Kühle (ORCID: https://orcid.org/0000-0002-6963-8892)
- Enric Monreal (ORCID: https://orcid.org/0000-0003-3293-0125)
- Jorge Correale (ORCID: https://orcid.org/0000-0003-4756-9889)
- Roberto Furlan (ORCID: https://orcid.org/0000-0001-7376-9425)
- Robert Hoepner (ORCID: https://orcid.org/0000-0002-0115-7021)
- Nicholas Schwab (ORCID: https://orcid.org/0000-0001-5494-9885)
- Samia Joseph Khoury (ORCID: https://orcid.org/0000-0003-3198-6063)
- Konrad Rejdak (ORCID: https://orcid.org/0000-0002-7019-6681)
- Àlex Rovira (ORCID: https://orcid.org/0000-0002-2132-6750)
- Michael Khalil (ORCID: https://orcid.org/0000-0002-5350-3328)
- Nicolás Fissolo (ORCID: https://orcid.org/0000-0002-7701-9346)
- Sergio Martínez‐Yélamos (ORCID: https://orcid.org/0000-0001-9889-2040)
- Andrew T. Chan (ORCID: https://orcid.org/0000-0001-7284-6767)
- Éric Thouvenot (ORCID: https://orcid.org/0000-0001-8671-7747)
- Joep Killestein (ORCID: https://orcid.org/0000-0002-6347-5957)
- Daniela Galimberti (ORCID: https://orcid.org/0000-0002-9284-5953)
- Frauke Zipp (ORCID: https://orcid.org/0000-0002-1231-1928)
- Luisa María Villar (ORCID: https://orcid.org/0000-0002-9067-3668)
- Gary Álvarez-Bravo
- Jelena Drulović (ORCID: https://orcid.org/0000-0002-4516-3458)
- Johanna Oechtering (ORCID: https://orcid.org/0000-0001-5359-7961)
- Elena Colombo (ORCID: https://orcid.org/0000-0002-5265-5055)
- Friedemann Paul
- Antonio Garcı́a-Merino
- Neus Téllez-Lara
- José Enrique-Martínez
- Jonas Schaller-Nagengast
Institutions
- Universitat de Vic - Universitat Central de Catalunya (ES)
- University of Bern (CH)
- Medical University of Lublin (PL)
- Universitat Autònoma de Barcelona (ES)
- Centre National de la Recherche Scientifique (FR)
- Innsbruck Medical University (AT)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Inserm (FR)
- University of Basel (CH)
- University of Milan (IT)
- Universidad de Alcalá (ES)
- Universität Innsbruck (AT)
- Johannes Gutenberg University Mainz (DE)
- Université de Montpellier (FR)
- Medical University of Graz (AT)
- Max Delbrück Center (DE)
- Universidad de Buenos Aires (AR)
- University Hospital of Bern (CH)
- Instituto de Salud Carlos III (ES)
- Bellvitge University Hospital (ES)
- University Hospital of Basel (CH)
- TUM Klinikum (DE)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Hospital Universitari i Politècnic La Fe (ES)
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- BioCruces Health research Institute (ES)
- Hospital Universitario Virgen Macarena (ES)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Vall d'Hebron Institut de Recerca (ES)
- University Hospital Münster (DE)
- American University of Beirut Medical Center (LB)
- Amsterdam Neuroscience (NL)
- Centar za Promociju Nauke (RS)
- Munich Cluster for Systems Neurology (DE)
- Institut d'Investigació Biomèdica de Girona (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Hospital Del Mar (ES)
- Hospital General Universitario de Alicante Doctor Balmis (ES)
- Instituto de Investigación Sanitaria de Santiago (ES)
- Amsterdam University Medical Centers (NL)
- University Hospital Ulm (DE)
- Hospital del Mar Research Institute (ES)
- Institut de Génomique Fonctionnelle (FR)
- Hospital Clínico Universitario de Valladolid (ES)
- Hospital Universitario Ramón y Cajal (ES)
- University of Rostock (DE)
- University of Bari Aldo Moro (IT)
- Technical University of Munich (DE)
- Université de Nîmes (FR)
- Universitat de Barcelona (ES)
- Charité - Universitätsmedizin Berlin (DE)
- Vrije Universiteit Amsterdam (NL)
- University of Gothenburg (SE)
Publication Details
- Journal
- JAMA Neurology
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1001/jamaneurol.2025.1481
- Citations
- 15
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 22.07
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Sanofi
- Massachusetts General Hospital
- Biogen
- Teva Pharmaceutical Industries
- Alexion Pharmaceuticals
- Celgene
- F. Hoffmann-La Roche
- Hexal AG
- American University of Beirut
- CSL Behring
- University of Victoria
- University of Bern
- Merck KGaA
- TG Therapeutics
- Mylan
- International Progressive MS Alliance
- Inselspital, Universitätsspital Bern
- Universitätsmedizin Göttingen
- Amsterdam University Medical Centers
- Horizon Therapeutics
- Multiple Sclerosis Society
- European Commission
- National Research Foundation
- Deutsche Forschungsgemeinschaft
- Institut National de la Santé et de la Recherche Médicale
- Vrije Universiteit Amsterdam
- Bundesministerium für Bildung und Forschung
- Centre National de la Recherche Scientifique
- Universitat de Barcelona
- Universidad de Alcalá
- Karl-Franzens-Universität Graz
- Medizinische Universität Innsbruck
- Medizinische Universität Graz
- Universitat Autònoma de Barcelona
- Universität Innsbruck
- Ipsen
- Neuraxpharm
- MedDay Pharmaceuticals
- Amsterdam Neuroscience
- Samsung
- EMD Serono
- Chugai Pharmaceutical
- Sanofi Genzyme
- Instituto de Salud Carlos III
- NIH Clinical Center
- Cilag